Jingsong Lu
No. 1630 Dongfang Road
Dongfang, 200127, China
Dongfang, 200127, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Mannose Glycation of Tumor-Associated Antigens via Intratumoral Maillard Reaction Mediated by a Photothermal Nano-Catalyst for Enhanced Antigen-Presenting Cell Targeting.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: April 13, 2026
Targeting VEGFR2 inhibition within a spatially-confined conduit promotes nerve self-resolution and alleviates mechanical allodynia.
Journal: Bioactive materials
Published: October 19, 2025
Metal ion-driven assembly for constructing a metal-phenolic network nanoparticle-loaded hydrogel as a tumor photothermal-immunotherapy agent.
Journal: Journal of materials chemistry. B
Published: July 28, 2025
Saponin-mediated cell membrane interference nanomedicine potentiates tumor chemo-immunotherapy via a perforin-granzyme-like mechanism.
Journal: Biomaterials science
Published: June 13, 2025
Self-assembled hybrid hydrogel microspheres create a bone marrow-mimicking niche for bone regeneration.
Journal: Bioactive materials
Published: April 28, 2025
Dynamic Evolution of Vascular Features Based on Magnetic Resonance Imaging to Predict Pathological Response, Patterns of Recurrence and Survival Outcomes in Breast Cancer Neoadjuvant Chemotherapy.
Journal: Current oncology (Toronto, Ont.)
Published: March 29, 2025
SHCBP1 drives tumor progression in triple-negative breast cancer.
Journal: Frontiers in oncology
Published: March 04, 2025
Measurement of Intratumor Heterogeneity and Its Changing Pattern to Predict Response and Recurrence Risk After Neoadjuvant Chemotherapy in Breast Cancer.
Journal: Current oncology (Toronto, Ont.)
Published: January 05, 2025
Stable or at least once HER2-low status during neoadjuvant chemotherapy confers survival benefit in patients with breast cancer.
Journal: Annals of medicine
Published: October 08, 2024
Survival outcomes, multidimensional prediction and subsequent therapy in patients with hormone receptor-positive advanced breast cancer receiving palbociclib: a real-world analysis.
Journal: Gland surgery
Published: August 17, 2024
RBC balanced immuno-inflammatory signatures identify advanced breast cancer patients on CDK4/6 inhibitors at increased risk of progression and death.
Journal: iScience
Published: July 26, 2024
Last Updated: 09/26/2026